Immediate Impact
43 standout
Citing Papers
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2023 Standout
Works of Peter Schuld being referenced
Large-scale imatinib dose–concentration–effect study in CML patients under routine care conditions
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Schuld | 134 | 109 | 22 | 53 | 15 | 192 | |
| Solomon Estren | 69 | 61 | 12 | 76 | 19 | 280 | |
| Ole Maywald | 136 | 85 | 20 | 38 | 11 | 200 | |
| A Drivsholm | 90 | 118 | 30 | 10 | 13 | 264 | |
| Dmitrij Kollins | 57 | 27 | 5 | 52 | 17 | 241 | |
| Clodagh Keohane | 157 | 181 | 5 | 72 | 14 | 251 | |
| Stéphanie E. Reitsma | 114 | 105 | 10 | 19 | 17 | 240 | |
| G Barbano | 83 | 30 | 12 | 107 | 17 | 281 | |
| Sloan J. Wilson | 84 | 83 | 20 | 7 | 10 | 185 | |
| Danielle Levine | 24 | 30 | 19 | 61 | 11 | 287 | |
| Soo-Young Choi | 142 | 114 | 19 | 56 | 18 | 215 |
All Works
Loading papers...